Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ciprofloxacin (inhalation use)

EU orphan designation number: EU/3/07/469   
Active ingredient: Ciprofloxacin (inhalation use)
Indication: Treatment of cystic fibrosis
Sponsor: Bayer Schering Pharma AG
D-13342 Berlin, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/08/2007 Centralised Orphan - Designation EMEA/OD/092/06 (2007)3837 of 03/08/2007
31/10/2007 Corrigendum (2007)3937 of 29/10/2007
26/05/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/092/06/T/01 (2009)4109 of 20/05/2009